Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(n/a)
# 5,185
Out of 5,241 analysts
26
Total ratings
n/a
Success rate
-33.25%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,475 → $1,275 | $1,031.64 | +23.59% | 3 | May 12, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $255 | $161.91 | +57.49% | 2 | Apr 23, 2026 | |
| MMED MiniMed Group | Initiates: Overweight | $19 | $10.80 | +75.93% | 1 | Mar 31, 2026 | |
| A Agilent Technologies | Maintains: Overweight | $180 → $160 | $111.70 | +43.24% | 2 | Mar 3, 2026 | |
| WAT Waters | Maintains: Equal-Weight | $423 → $350 | $329.22 | +6.31% | 2 | Feb 23, 2026 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $302.89 | -5.91% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $40.05 | +224.59% | 7 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $322.32 | -17.47% | 8 | Jul 31, 2025 |
Mettler-Toledo International
May 12, 2026
Maintains: Equal-Weight
Price Target: $1,475 → $1,275
Current: $1,031.64
Upside: +23.59%
Danaher
Apr 23, 2026
Maintains: Overweight
Price Target: $270 → $255
Current: $161.91
Upside: +57.49%
MiniMed Group
Mar 31, 2026
Initiates: Overweight
Price Target: $19
Current: $10.80
Upside: +75.93%
Agilent Technologies
Mar 3, 2026
Maintains: Overweight
Price Target: $180 → $160
Current: $111.70
Upside: +43.24%
Waters
Feb 23, 2026
Maintains: Equal-Weight
Price Target: $423 → $350
Current: $329.22
Upside: +6.31%
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $302.89
Upside: -5.91%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $40.05
Upside: +224.59%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $322.32
Upside: -17.47%